The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study

Biologics are used for ankylosing spondylitis (AS), psoriasis, and psoriatic arthritis (PsA) treatment. The association between biologics and the development of hematologic malignancies is controversial, and data on patients with AS, psoriasis, and PsA are scarce. This retrospective cohort study use...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chia-Jung, Lin, Yu-Chih, Chen, Chung-Yu, Hung, Chih-Hsing, Lin, Yi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526259/
https://www.ncbi.nlm.nih.gov/pubmed/37760951
http://dx.doi.org/10.3390/biomedicines11092510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526259/
https://www.ncbi.nlm.nih.gov/pubmed/37760951
http://dx.doi.org/10.3390/biomedicines11092510

Ejemplares similares